Monthly Archives: September 2010

Oracle Launches Oracle Health Sciences Institute

The ability to develop the right technology to support patient needs and anticipate changes in the health sciences industry is pivotal in advancing how next-generation healthcare will be defined and administered. This week, Oracle announced the creation of the Oracle Health Sciences Institute (OHSI), in partnership with Sun Labs. The Institute is focused on research […]
Posted in R&D | Tagged | 1 Comment

Pfizer Ends Sutent Trial

Successful cancer drug Sutent may not be effective in prolonging life for patients with castration-resistant prostate cancer. This week, Pfizer announced that it has ended a Phase III trial of cancer drug Sutent. The drug, which was being tested as a treatment for patients with prostate cancer, has already been approved as a treatment for […]
Posted in News | Tagged , , | 1 Comment

Endo Pharmaceuticals Acquires Qualitest for $1.2 Billion

The biotech aims to deliver more comprehensive healthcare solutions across its diversified businesses in branded pharmaceuticals, generics, and devices & services in key therapeutic areas with this deal. Endo Pharmaceuticals has entered into an agreement to acquire privately held Qualitest Pharmaceuticals for approximately $1.2 billion in cash. Qualitest, the sixth-largest US generics company as measured […]
Posted in Deals | Tagged , | Leave a comment

Economics of Alzheimer’s Disease Prove Shocking

The mind is a terrible thing to waste—the global burden of caring for people with dementia is so big that its costs now exceed total annual health spending in the world’s five largest economies outside the US. The World Alzheimer Report 2010, recently published by Alzheimer’s Disease International (ADI), outlines the global economic impact of […]
Posted in R&D | 1 Comment

FDA and CMS: A Partnership On Approval

FDA announced last week that the lengthy delay that punctuates the initial approval of a medical product and it reaching the hands of consumers is to be addressed in a planned project in which the Agency will make joint approval decisions with the Medicare division of the Centers for Medicare and Medicaid Services (CMS). The […]
Posted in FDA, Regulatory | Tagged , , , , | 2 Comments
  • Categories

  • Meta